先声药业集团有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (国市监处〔2021〕1号 · 市场监管总局发布先声药业集团有限公司滥用市场支配地位案行政处罚决定书), from 29 January 2021.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.

Details

Company

先声药业集团有限公司

Authority

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)

Decision

Abuse of a dominant market position

Grounds and details, as published

国市监处〔2021〕1号 · 市场监管总局发布先声药业集团有限公司滥用市场支配地位案行政处罚决定书

From

29 January 2021

Until

—

Status

End date not published

Source

https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_9176e6ec9d04486c9cdff678568659ad.html

Licence

Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)